Skip to Content
Søg Menu

Highlights from ASCO GU 2021 by Thomas Powles, Barts Cancer Centre, London

In this MEDtalk Thomas Powles, Professor of Genitourinary Oncology, Director, Barts Cancer Centre, London gives his perspective of new data for metastatic urothelial carcinoma and metastatic renal cell cancer presented at ASCO GU 2021.

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Related

Ahmed Rehan

Real-World Data on Maintenance Avelumab Treatment

/ Ahmed Rehan
ASCOGU24Blærecancer Play the Video 2:14
Dag Rune Stormoen

Highlights fra ASCO GU 2024 om blærekræft i en dansk kontekst

/ Dag Rune Stormoen
ASCOGU24Blærecancer Play the Video 6:41
Petros Grivas

Long-Term Patient-Reported Outcomes Data from the JAVELIN Bladder 100 Trial in Patients with Advanced Urothelial Carcinoma

/ Petros Grivas
ASCOGU24Blærecancer Play the Video 02:14
Andrea Apolo

Results from Study of Pembrolizumab in Muscle-Invasive and Locally Advanced Urothelial Carcinoma

/ Andrea Apolo
ASCOGU24Blærecancer Play the Video 02:02
Philippe Barthelemy

Real-World Data on Avelumab as 1L Maintenance Treatment

/ Philippe Barthelemy
ASCOGU24Blærecancer Play the Video 02:48
Jeanny B. Aragon-Ching

JAVELIN Bladder 100 Trial: Strong Avelumab Maintenance Efficacy in High BMI Patients

/ Jeanny B. Aragon-Ching
ASCOGU24BMIBlærecancer Play the Video 02:40
Per Pfeiffer

Immunterapi som alternativ til traditionel behandling ved rektumcancer?

/ Per Pfeiffer
ASCOGI24ColorektalcancerImmunterapi Play the Video 3:54
Srikala Sridhar

Promising Results for Enfortumab Vedotin in Neoadjuvant Treatment of Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

/ Srikala Sridhar
Blærecancer Play the Video 05:10
Daniel Heinrich

ESMO 2023: Dobling av overlevelsesraten ved innovativ behandling for metastatisk blærekreft

/ Daniel Heinrich
ESMO23Blærecancer Play the Video 2:52
Back to top